Effectiveness and Safety of Baricitinib for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis or Chronic Anterior Antinuclear Antibody Positive Uveitis in Children

被引：0
|
作者：
Ramanan, Athimalaipet [1 ]
Guly, Catherine [2 ]
Simonini, Gabriele [3 ]
Keller, Stuart [4 ]
Sen, Priyanka [4 ]
Holzkaemper, Thorsten [4 ]
Quartier, Pierre [5 ]
机构：
[1] Bristol Royal Hosp Children, Bristol, Avon, England
[2] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England
[3] Univ Florence, Meyer Childrens Hosp IRCCS, Florence, Toscana, Italy
[4] Eli Lilly & Co, Indianapolis, IN USA
[5] Univ Paris Cite, IMAGINE Inst, Necker Childrens Hosp, Paris 15, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0379
引用
收藏
页码：751 / 752
页数：2
相关论文
共 50 条
  • [1] New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Chronic Anterior Uveitis
    Foeldvari, Ivan
    Maccora, Ilaria
    Petrushkin, Harry
    Rahman, Najiha
    Anton, Jordi
    de Boer, Joke
    Calzada-Hernandez, Joan
    Carreras, Elisa
    Diaz, Jesus
    Edelsten, Clive
    Angeles-Han, Sheila T.
    Heiligenhaus, Arnd
    Miserocchi, Elisabetta
    Nielsen, Susan
    Saurenmann, Rotraud K.
    Stuebiger, Nicole
    Baquet-Walscheid, Karoline
    Furst, Daniel
    Simonini, Gabriele
    ARTHRITIS CARE & RESEARCH, 2023, 75 (05) : 975 - 982
  • [2] Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)
    Athimalaipet V. Ramanan
    Catherine M. Guly
    Stuart Y. Keller
    Douglas E. Schlichting
    Stephanie de Bono
    Ran Liao
    Pierre Quartier
    Trials, 22
  • [3] Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)
    Ramanan, Athimalaipet, V
    Guly, Catherine M.
    Keller, Stuart Y.
    Schlichting, Douglas E.
    de Bono, Stephanie
    Liao, Ran
    Quartier, Pierre
    TRIALS, 2021, 22 (01)
  • [4] Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
    Elena Zholobova
    Lelia Galstian
    MN Nikolaeva
    OY Loskutova
    Pediatric Rheumatology, 12 (Suppl 1)
  • [5] Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis
    Tynjala, P.
    Kotaniemi, K.
    Lindahl, P.
    Latva, K.
    Aalto, K.
    Honkanen, V.
    Lahdenne, P.
    RHEUMATOLOGY, 2008, 47 (03) : 339 - 344
  • [6] Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis
    Rosa Bou
    Estíbaliz Iglesias
    Jordi Antón
    Current Rheumatology Reports, 2014, 16
  • [7] Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis
    Bou, Rosa
    Iglesias, Estibaliz
    Anton, Jordi
    CURRENT RHEUMATOLOGY REPORTS, 2014, 16 (08)
  • [8] Classification Criteria for Juvenile Idiopathic Arthritis-Associated Chronic Anterior Uveitis
    Jabs, Douglas A.
    Acharya, Nisha R.
    Chee, Soon-Phaik
    Goldstein, Debra
    Murray, Philip, I
    Oden, Neal
    Palestine, Alan G.
    Rosenbaum, James T.
    Thorne, Jennifer E.
    Trusko, Brett E.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 228 : 192 - 197
  • [9] Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis
    Molina, Clara
    Modesto, Consuelo
    Martin-Begue, Nieves
    Arnal, Cristina
    CLINICAL RHEUMATOLOGY, 2013, 32 (11) : 1673 - 1675
  • [10] Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis
    Clara Molina
    Consuelo Modesto
    Nieves Martín-Begué
    Cristina Arnal
    Clinical Rheumatology, 2013, 32 : 1673 - 1675
12345